Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Biomedica ; 38(0): 95-105, 2018 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-30184370

RESUMO

INTRODUCTION: Aedes (Stegomyia) aegypti is the vector for dengue, chikungunya, and Zika arboviruses. Bti-CECIF is a bioinsecticide designed and developed in the form of a solid tablet for the control of this vector. It contains Bacillus thuringiensis var. israelensis (Bti) serotype H-14. OBJECTIVE: To evaluate under semi-field and field conditions the efficacy and residual activity of Bti-CECIF tablets on Aedes aegypti larvae in two Colombian municipalities. MATERIALS AND METHODS: We tested under semi-field conditions in plastic tanks (Rotoplast™) four different Bti doses (0.13, 0.40, 0.66 and 0.93 mg/L) in the municipality of Apartadó, department of Antioquia, to assess Bti-CECIF efficacy (percentage of reduction of larval density) and the residual activity in water tanks containing A. aegypti third-instar larvae. The efficacy and residuality of the most lethal dose were subsequently evaluated under field conditions in cement tanks in the municipality of San Carlos, department of Córdoba. RESULTS: Under semi-field conditions, the highest tested dose exhibited the greatest residual activity (15 days) after which larval mortality was 80%. Under field conditions, the highest tested Bti-CECIF doses showed 100% mortality and exhibited a residual activity of seven days in 90% of the tanks. CONCLUSION: Bti-CECIF tablets effectively controlled A. aegypti larvae under field conditions for up to seven days post-treatment.


Assuntos
Aedes/microbiologia , Bacillus thuringiensis/fisiologia , Controle de Mosquitos , Mosquitos Vetores/microbiologia , Controle Biológico de Vetores , Aedes/crescimento & desenvolvimento , Animais , Colômbia , Larva/microbiologia , Mosquitos Vetores/crescimento & desenvolvimento , Comprimidos
2.
Biomédica (Bogotá) ; 38(supl.2): 95-105, ago. 2018. tab, graf
Artigo em Inglês | LILACS | ID: biblio-974011

RESUMO

Introduction: Aedes (Stegomyia) aegypti is the vector for dengue, chikungunya, and Zika arboviruses. Bti-CECIF is a bioinsecticide designed and developed in the form of a solid tablet for the control of this vector. It contains Bacillus thuringiensis var. israelensis (Bti) serotype H-14. Objective: To evaluate under semi-field and field conditions the efficacy and residual activity of Bti-CECIF tablets on Aedes aegypti larvae in two Colombian municipalities. Materials and methods: We tested under semi-field conditions in plastic tanks (Rotoplast™) four different Bti doses (0.13, 0.40, 0.66 and 0.93 mg/L) in the municipality of Apartadó, department of Antioquia, to assess Bti-CECIF efficacy (percentage of reduction of larval density) and the residual activity in water tanks containing A. aegypti third-instar larvae. The efficacy and residuality of the most lethal dose were subsequently evaluated under field conditions in cement tanks in the municipality of San Carlos, department of Córdoba. Results: Under semi-field conditions, the highest tested dose exhibited the greatest residual activity (15 days) after which larval mortality was 80%. Under field conditions, the highest tested Bti-CECIF doses showed 100% mortality and exhibited a residual activity of seven days in 90% of the tanks. Conclusion: Bti-CECIF tablets effectively controlled A. aegypti larvae under field conditions for up to seven days post-treatment.


Introducción. Aedes (Stegomyia) aegypti es el vector de los arbovirus del dengue, el chikungunya y el Zika. Para el control de este vector, se diseñó y desarrolló un bioinsecticida en presentación de tableta sólida, el Bti-CECIF, que contiene Bacillus thuringiensis var. israelensis (Bti) de serotipo H-14. Objetivo. Evaluar en condiciones de 'semicampo' y de campo, la eficacia y la actividad residual de las tabletas de Bti-CECIF en larvas de A. aegypti en dos municipios colombianos. Materiales y métodos. En el municipio de Apartadó, departamento de Antioquia, se probaron bajo condiciones de 'semicampo' en tanques de plástico de 250 l (Rotoplast™) cuatro dosis diferentes de Bti (0,13, 0,40, 0,66 y 0,93 mg/l) para evaluar la eficacia del Bti-CECIF (porcentaje de reducción de la densidad larvaria) y la actividad residual en tanques de agua que contenían larvas de tercer estadio de A. aegypti. La eficacia y el efecto residual de la dosis más letal fueron posteriormente evaluadas en tanques de cemento bajo condiciones de campo en el municipio de San Carlos, departamento de Córdoba. Resultados. Bajo condiciones de 'semicampo', la mayor dosis probada exhibió la mayor actividad residual (15 días), después de lo cual la mortalidad de las larvas fue de 80 %. Bajo condiciones de campo, la máxima dosis probada de Bti-CECIF mostró una mortalidad de 100 % y exhibió una actividad residual de siete días en el 90 % de los tanques. Conclusión. Las tabletas Bti-CECIF controlaron eficazmente A. aegypti en condiciones de campo durante siete días a partir de su aplicación.


Assuntos
Bacillus thuringiensis , Aedes , Vírus Chikungunya , Colômbia , Dengue , Vetores de Doenças , Zika virus
3.
Rev. cuba. plantas med ; 17(4): 330-342, oct.-dic. 2012.
Artigo em Espanhol | LILACS | ID: lil-656388

RESUMO

Introducción: los vinagres producidos durante la pirolisis de Guadua angustifolia Kunth, son una fuente de compuestos fenólicos con alta actividad antioxidante; en la literatura se reporta que se han logrado extraer cerca de 400 compuestos de interés de especies similares, con aplicación farmacéutica, cosmética y alimentaria. Debido a este potencial, la guadua representa una importante alternativa de desarrollo científico, tecnológico y económico. Objetivos: identificar los compuestos fenólicos del vinagre de guadua, investigar su capacidad antioxidante y medir la eficiencia del proceso de refinación para incorporar el vinagre refinado en una formulación alimenticia. Métodos: el vinagre se guadua se caracterizó por cromatografía de gases y luego se sometió a un proceso de destilación fraccionado y a un proceso enzimático para eliminar compuestos tóxicos. Posteriormente se usaron diferentes concentraciones de vinagre refinado y de maltodextrina para la elaboración de las diferentes formulaciones. La actividad antioxidante en las formulaciones se determinó por los métodos ABTS y DPPH, y la concentración de siringol se cuantificó por HPLC. Resultados: los procesos de refinación lograron eliminar los compuestos tóxicos casi en su totalidad. Las formulaciones alimenticias preparadas sobre la base de vinagre de guadua presentan una actividad antioxidante hasta de 940,16 µmol/L. La concentración de siringol en las formulaciones oscila entre 20 y 100 ppm. Conclusiones: se logró incorporar el vinagre de guadua en el desarrollo de una bebida alimenticia con propiedades antioxidantes. La actividad antioxidante resultó 10 veces mayor que las bebidas comerciales.


Introduction: the vinegars produced during the pyrolysis of Guadua angustifolia Kunth, are a source of phenolic compounds with high antioxidant activity. There are reports in the international literature about the extraction of nearly 400 compounds from other similar species with pharmaceutical, cosmetic and food applications. Because of this potential, Guadua is an important alternative for scientific, technological and economic development. Objectives: to identify the phenolic compounds from guadua vinegar, to further investigate their antioxidant capacity and to measure the efficiency of the refining process to incorporate the refined vinegar into the food formulation. Methods: guadua vinegar was characterized through the gas chromatography technique and then was subjected to a fractional distillation process and to an enzymatic process for removing toxic compounds. Afterwards, different concentrations of maltodextrin and refined vinegar were used to make the formulations. Antioxidant activity in the formulations was determined by the ABTS and DPPH methods and the concentration of syringol was measured by HPLC. Results: the refining process managed to eliminate almost all the toxic compounds. The food formulations with guadua vinegar had antioxidant activity of up 940.16 µmol/L. The syringol concentration in the formulations ranged 20 to 100 ppm. Conclusions: it was possible to incorporate guadua vinegar in the preparation of a food beverage with antioxidant properties. The antioxidant activity of this beverage was 10 times greater than that of the commercial ones.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA